1. Home
  2. GOVX vs CDIO Comparison

GOVX vs CDIO Comparison

Compare GOVX & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOVX
  • CDIO
  • Stock Information
  • Founded
  • GOVX 2001
  • CDIO 2017
  • Country
  • GOVX United States
  • CDIO United States
  • Employees
  • GOVX N/A
  • CDIO N/A
  • Industry
  • GOVX Biotechnology: Pharmaceutical Preparations
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • GOVX Health Care
  • CDIO Health Care
  • Exchange
  • GOVX Nasdaq
  • CDIO Nasdaq
  • Market Cap
  • GOVX 19.5M
  • CDIO 20.2M
  • IPO Year
  • GOVX N/A
  • CDIO N/A
  • Fundamental
  • Price
  • GOVX $1.67
  • CDIO $0.50
  • Analyst Decision
  • GOVX Strong Buy
  • CDIO Buy
  • Analyst Count
  • GOVX 5
  • CDIO 1
  • Target Price
  • GOVX $14.20
  • CDIO $2.00
  • AVG Volume (30 Days)
  • GOVX 569.4K
  • CDIO 2.5M
  • Earning Date
  • GOVX 03-03-2025
  • CDIO 03-31-2025
  • Dividend Yield
  • GOVX N/A
  • CDIO N/A
  • EPS Growth
  • GOVX N/A
  • CDIO N/A
  • EPS
  • GOVX N/A
  • CDIO N/A
  • Revenue
  • GOVX $3,090,161.00
  • CDIO $35,688.00
  • Revenue This Year
  • GOVX N/A
  • CDIO $228.74
  • Revenue Next Year
  • GOVX $150.51
  • CDIO $854.55
  • P/E Ratio
  • GOVX N/A
  • CDIO N/A
  • Revenue Growth
  • GOVX N/A
  • CDIO 180.90
  • 52 Week Low
  • GOVX $1.09
  • CDIO $0.19
  • 52 Week High
  • GOVX $11.18
  • CDIO $1.86
  • Technical
  • Relative Strength Index (RSI)
  • GOVX 37.32
  • CDIO 45.05
  • Support Level
  • GOVX $1.50
  • CDIO $0.47
  • Resistance Level
  • GOVX $1.79
  • CDIO $0.69
  • Average True Range (ATR)
  • GOVX 0.13
  • CDIO 0.08
  • MACD
  • GOVX 0.01
  • CDIO 0.01
  • Stochastic Oscillator
  • GOVX 29.82
  • CDIO 33.88

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.

Share on Social Networks: